Nebicard
Nebicard is nebivolol 2.5/5 mg tablets from Torrent — ultra-selective beta-1 blocker with nitric-oxide-mediated vasodilation. Preferred beta-blocker in elderly, metabolic syndrome, erectile dysfunction patients. For hypertension (5-10 mg once daily) and elderly heart failure. Better metabolic profile than atenolol/metoprolol.
✓ Medically reviewed by Morgan Ellis — Pharmacy Researcher · 8 years experience · Last reviewed: May 2026
⚡ Quick Answer — What is Nebicard?
Nebicard is a 2.5 mg / 5 mg nebivolol tablet from Torrent Pharmaceuticals — ultra-selective beta-1 blocker with additional nitric-oxide-mediated vasodilation. Primary use is hypertension; also used for angina, arrhythmia control, post-myocardial-infarction secondary prevention. Preferred in elderly, metabolic syndrome, and patients with erectile dysfunction. Typical hypertension dose: 5 mg once daily (range 2.5-10 mg). Start 2.5 mg in elderly or renal impairment. Contraindicated in asthma (relative for cardioselective agents; absolute for non-selective), severe bradycardia, second/third-degree heart block, acute decompensated heart failure, and phaeochromocytoma without prior alpha-blockade. Do NOT stop abruptly — taper over 1-2 weeks to avoid rebound tachycardia / angina / MI.
📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.
Why order from MedsBase
Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging — no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor — never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.
What Is Nebicard?
Nebicard is an oral tablet containing nebivolol 2.5 mg / 5 mg from Torrent Pharmaceuticals, supplied in 30-180 tablets. Nebivolol is a ultra-selective beta-1 blocker with additional nitric-oxide-mediated vasodilation. Third-generation beta-blocker with the highest beta-1 selectivity of any clinically-used agent (roughly 10× more selective than bisoprolol) and a unique property: it releases nitric oxide in the vascular endothelium, producing direct vasodilation. Evidence from the SENIORS trial for elderly heart failure (heart failure with preserved ejection fraction included — unusual for a beta-blocker).
How Nebivolol Lowers Blood Pressure
Beta-blockers reduce blood pressure through four mechanisms:
- Reduction of cardiac output — beta-1 blockade in the sinoatrial node reduces heart rate, and blockade in ventricular myocardium reduces contractility. Lower cardiac output = lower blood pressure.
- Renin-angiotensin suppression — beta-1 blockade in juxtaglomerular cells reduces renin release, lowering angiotensin II and aldosterone over 2-4 weeks. This accounts for much of the long-term BP effect.
- Central sympathetic reduction — lipophilic beta-blockers cross the blood-brain barrier and reduce central sympathetic outflow.
- Nitric-oxide-mediated vasodilation (nebivolol-specific) — endothelial NO release produces direct arterial relaxation alongside the beta-blockade effect.
Beta-blockers are moderately lipophilic. Plasma half-life of nebivolol is 10-44 hours (depending on metaboliser status).
Approved and Evidence-Based Uses
- Hypertension (primary indication)
- Heart failure in elderly (>70 years) — SENIORS evidence
- Hypertension with metabolic syndrome — favourable on glucose/lipid profile vs older beta-blockers
- Hypertension in erectile-dysfunction patients — less sexual-dysfunction impact than propranolol / atenolol; in some studies, improved endothelial function improves erectile function
Nebicard Dosage
Adult hypertension dose: 5 mg once daily (range 2.5-10 mg). Start 2.5 mg in elderly or renal impairment.
Start low, titrate upward over 2-4 weeks to target BP (typically <140/90 in uncomplicated hypertension; <130/80 in diabetes, chronic kidney disease, or established cardiovascular disease). Check resting pulse before each dose-increase — do not titrate if <55 bpm.
Monitoring:
- Resting pulse and BP at 2, 4, and 8 weeks after starting or dose change
- Baseline ECG if any cardiac history; periodic ECG if symptoms change
Administration: swallow whole with water. Take at approximately the same time each day.
Discontinuation: NEVER stop abruptly. Taper over 1-2 weeks (reduce by 25-50% every 3-5 days). Abrupt discontinuation causes rebound tachycardia, worsened angina, and — in patients with coronary disease — can precipitate myocardial infarction. This is one of the most important safety points for beta-blockers.
Side Effects
Common (>5%):
- Fatigue, lethargy — often adapts over 2-4 weeks
- Cold hands and feet (peripheral vasoconstriction)
- Bradycardia (check pulse; stop if <50 bpm)
- Exercise intolerance — maximum heart rate is blunted by beta blockade
- Dizziness, postural hypotension
- CNS effects possible but less common than with propranolol
- Postural dizziness (more common due to vasodilator component)
Less common: depression, reduced libido / erectile dysfunction, gastrointestinal upset, Raynaud-like cold intolerance, bronchospasm (more common with non-selective agents).
Important but uncommon:
- Masked hypoglycaemia in diabetics — beta-blockers blunt the tachycardia / tremor warning signs of low blood sugar. Monitor glucose more carefully; prefer bisoprolol in insulin-treated diabetes.
- Bronchospasm — can be severe in asthma / COPD. Absolute contraindication for non-selective agents; relative for cardioselective.
- Heart block or worsening heart failure — in susceptible patients. Start low, titrate slowly.
Contraindications & Cautions
- Severe asthma / severe COPD — relative contraindication (cardioselectivity is relative, not absolute)
- Second or third-degree atrioventricular block (without pacemaker)
- Sinus bradycardia <50 bpm
- Cardiogenic shock, decompensated heart failure requiring inotropes
- Severe peripheral arterial disease, Raynaud’s syndrome (relative)
- Phaeochromocytoma without prior alpha-blockade — paradoxical hypertensive crisis (never use a beta-blocker before alpha-blocker)
- Severe hepatic impairment (for extensively hepatic-metabolised agents: propranolol, metoprolol, carvedilol, labetalol)
- Severe renal impairment — dose adjustment needed for renal-excreted agents (atenolol, nadolol)
- Hypersensitivity to nebivolol
Pregnancy: Category C; cross the placenta; small risk of intrauterine growth restriction, neonatal bradycardia, and hypoglycaemia. Use only if benefit clearly outweighs risk; labetalol is the pregnancy-preferred beta-blocker.
Breastfeeding: small amounts in breast milk; generally considered compatible with monitoring.
Drug Interactions
- Verapamil, diltiazem (non-dihydropyridine CCBs) — additive bradycardia, heart block, and negative inotropy; generally avoid combination. Dihydropyridine CCBs (amlodipine, nifedipine) are safer to combine with beta-blockers.
- Other beta-blockers — do not combine; additive bradycardia
- Clonidine — if stopping clonidine, stop the beta-blocker first (several days before) to avoid rebound hypertensive crisis
- Insulin and sulphonylureas — mask hypoglycaemia warning signs; monitor glucose closely
- NSAIDs — reduce the antihypertensive effect of beta-blockers; avoid chronic combination
- Alcohol — additive hypotension and CNS depression (particularly for lipophilic agents)
Beta-Blocker Class at a Glance
| Beta-blocker | Selectivity | Best for |
|---|---|---|
| Propranolol (Inderal, Ciplar, Beloc) | Non-selective | Migraine, tremor, thyrotoxicosis, performance anxiety, HTN |
| Metoprolol | Cardioselective | Post-MI, HF-REF (succinate ER), angina, AF rate control |
| Carvedilol | Non-selective + α-1 | HF-REF (mortality evidence), post-MI |
| Bisoprolol | Highly cardioselective | HF-REF, HTN, angina, AF rate control |
| Nebivolol | Ultra-selective + NO | Elderly, metabolic syndrome, erectile dysfunction |
| Atenolol | Cardioselective (hydrophilic) | Angina, AF rate control (second-line for HTN) |
| Labetalol | Non-selective + α-1 | Pregnancy hypertension, hypertensive crisis |
Preferred beta-blocker in elderly patients, patients with metabolic syndrome or impaired glucose tolerance, and men with erectile dysfunction. Ultra-high beta-1 selectivity means it is generally tolerated in mild-to-moderate asthma (still not absolutely safe; use caution and monitor). NO-mediated vasodilation gives it a BP-lowering profile closer to a CCB than a classical beta-blocker.
Storage
Store Nebicard below 25°C. Keep out of reach of children — accidental paediatric beta-blocker ingestion can cause life-threatening bradycardia and hypoglycaemia.
Frequently Asked Questions
How long does Nebicard take to lower blood pressure?
You should see some BP reduction within 1-2 days of starting; the full antihypertensive effect takes 2-4 weeks (driven by the gradual renin-angiotensin suppression, not the immediate heart-rate effect). Measure BP at home at the same time each day to track response.
Can I take Nebicard if I have asthma?
Nebivolol is ultra-selective + NO release, so it is relatively safer in asthma than non-selective agents. However, cardioselectivity is relative — at higher doses beta-2 blockade can still occur. In severe or brittle asthma, avoid all beta-blockers if possible. In mild asthma or COPD, use with monitoring and inhaler access.
Why should I never stop Nebicard abruptly?
Abrupt discontinuation causes rebound tachycardia and worsened angina within 24-48 hours, driven by up-regulation of beta receptors during chronic blockade. In patients with coronary artery disease, this can precipitate myocardial infarction or unstable angina. Always taper over 1-2 weeks when stopping.
Will Nebicard affect my exercise performance?
Yes — beta blockade blunts the heart-rate response to exercise, so your maximum pulse is lower and you fatigue faster at high intensities. For recreational exercise most people adapt; for competitive endurance athletes, beta-blockers can meaningfully impair performance and are banned in precision sports (shooting, archery — where they reduce physiological tremor).
Will Nebicard affect my blood sugar if I have diabetes?
Beta-blockers mask the tachycardia / tremor / palpitation warning signs of hypoglycaemia, making low blood sugar harder to detect. They can also blunt the counter-regulatory glucose response. Monitor glucose more frequently on a beta-blocker, particularly if on insulin or sulphonylureas. Nebivolol and bisoprolol have the best metabolic profile.
Can I drink alcohol on Nebicard?
Moderate alcohol is generally acceptable but alcohol potentiates the hypotensive and CNS-depressant effects. Stand up slowly after drinking. Alcohol is also an independent BP-raiser; reducing intake can improve BP control independent of Nebicard.
Does Nebicard cause weight gain?
Older beta-blockers (propranolol, atenolol, metoprolol) are associated with modest weight gain (1-3 kg) and worsening of insulin sensitivity over time. Nebivolol and carvedilol are weight-neutral or slightly weight-favourable due to their vasodilator components. For patients with metabolic syndrome, nebivolol is the preferred beta-blocker when one is needed.
Is Nebicard safe in pregnancy?
Category C. Use only if benefit clearly outweighs risk. For antihypertensive use in pregnancy, labetalol is the preferred beta-blocker; methyldopa and nifedipine are the two other pregnancy-safe options.
Can I take Nebicard with other BP medications?
Yes — beta-blockers combine well with dihydropyridine calcium-channel blockers (amlodipine), ACE inhibitors (ramipril, lisinopril), ARBs (losartan, telmisartan, olmesartan), and thiazide diuretics (HCTZ). Avoid combination with non-dihydropyridine CCBs (verapamil, diltiazem) — additive bradycardia and heart-block risk.
Where can I buy Nebicard online?
You can buy Nebicard (nebivolol 2.5 mg / 5 mg tablet, 30-180 tablets) from MedsBase with discreet packaging and worldwide shipping.
Related Beta-Blockers & Antihypertensives
- Beloc — Propranolol 10/20/40 mg
- Carloc — Carvedilol 3.125 mg (HF starter)
- Ciplar — Propranolol 10 mg (Cipla)
- Inderal — Propranolol IR 20/40 mg (AstraZeneca)
- P-Nolol SR — Propranolol 80 mg sustained-release
- Provanol SR — Propranolol 80 mg SR
- Browse all High Blood Pressure Medications
Related Alternatives
Other products in Chronic Conditions that customers also view:
More options in High Blood Pressure Medication
Ranked by recent MedsBase order volume — what other customers in this category are picking.
| Strength | 2.5 mg, 5 mg |
|---|---|
| Quantity | 30 Tablet/s, 60 Tablet/s, 90 Tablet/s |
| Pharma Form | Tablet/s |
| Manufacturer | Torrent Pharma |
| Treatment | High blood pressure |
| Generic Brand | Nebivolol |
Nebicard
Q & A
Nebicard
Related products
Reviews
There are no reviews yet